Press Releases
May 17, 2017
U.S. Rep. Gus Bilirakis (FL-12) participated in a key House technology panel today to examine emergency alert systems throughout the country and consider the possibilities of new methods of alerting the public to emergencies.
May 16, 2017
As President Trump welcomes Turkish President Recep Tayyip Erdogan to the White House this week, U.S. Rep. Gus Bilirakis (FL-12) joined a bipartisan letter to the Trump Administration expressing concern for human rights and democracy in Turkey.
Issues:Foreign Affairs
May 12, 2017
U.S. Rep. Gus Bilirakis (FL-12) congratulated five students from Florida’s 12th Congressional District who have been accepted to one of the nation’s prestigious service academies.
May 9, 2017
U.S. Rep. Gus Bilirakis (FL-12) announced that Clare Hernandez, a student from Dade City, Florida, has won the 2017 Congressional Art Competition for her pencil drawing titled “Portrait of an Unknown Soldier.”
May 4, 2017
U.S. Rep. Gus Bilirakis (FL-12) released the following statement on the American Health Care Act (H.R. 1628).
Issues:Health Care
May 3, 2017
U.S. Rep. Gus Bilirakis released the following statement after voting against the fiscal year 2017 spending bill (H.R. 244, the Consolidated Appropriations Act, 2017).
May 2, 2017
U.S. Rep. Gus Bilirakis (FL-12) announced today the Army Corps of Engineers has approved a critical next step for the Ridge Road project.
May 2, 2017
– U.S. Rep. Gus Bilirakis today announced nine teachers from Pasco and Pinellas schools have been nominated for the Teacher of the Year Award.
April 28, 2017
U.S. Rep. Gus Bilirakis (FL-12) announced his support for legislation to prevent Members of Congress from exempting themselves and their staff from the American Health Care Act (AHCA).
Issues:Health Care
April 25, 2017
Washington, D.C. – U.S. Rep. Gus Bilirakis (FL-12) took to the U.S. House floor today to applaud $27 million in new grant funding for Florida to combat the opioid crisis. Click here to learn more about the grant, which is the first of two rounds of funding secured by Bilirakis in the 21st Century Cures Act.